179 related articles for article (PubMed ID: 828444)
1. Treatment of lupus nephritis.
Pollak VE
Adv Nephrol Necker Hosp; 1976; 6():137-61. PubMed ID: 828444
[No Abstract] [Full Text] [Related]
2. Overview of treatment of lupus nephropathy.
Coggins CH
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):197-200. PubMed ID: 7102668
[No Abstract] [Full Text] [Related]
3. Cytotoxic drug treatment of lupus nephritis.
Donadio JV; Holley KE; Ilstrup DM
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of lupus-nephritis using corticosteroids and immunosuppressive agents].
Kampf D; Baethke R
Dtsch Med Wochenschr; 1974 Jun; 99(26):1420-3. PubMed ID: 4135099
[No Abstract] [Full Text] [Related]
5. [Controlled trial of cyclophosphamide, azathioprine and chlorambucil in lupus nephritis (the double-blind method)].
Ivanova MM; Nasonova VA; Solov'ev SK; Akhnazarova VD; Speranskiĭ AI
Vopr Revm; 1981; (2):11-8. PubMed ID: 7034366
[No Abstract] [Full Text] [Related]
6. The clinical course of lupus nephritis: relationship to the renal histologic findings.
Pollak VE; Pirani CL; Dujovne I; Dillard MG
Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1167-81. PubMed ID: 4139685
[No Abstract] [Full Text] [Related]
7. Evaluation of treatment in lupus nephritis: effects of prednisone.
Pollak VE; Dosekun AK
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):170-7. PubMed ID: 7102665
[TBL] [Abstract][Full Text] [Related]
8. Lupus nephritis: long-term follow-up.
Cameron JS; Jones MB
Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1187-91. PubMed ID: 4215066
[No Abstract] [Full Text] [Related]
9. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
[No Abstract] [Full Text] [Related]
10. [Lupus nephritis: treatment with intravenous pulses of methylprednisolone and cyclophosphamide].
Giganti J; Eimon A; Frega N; Hübscher O; Arana RM
Medicina (B Aires); 1984; 44(2):219-20. PubMed ID: 6537461
[No Abstract] [Full Text] [Related]
11. [Morphological and immunohistochemical changes in the kidneys and skin in systemic lupus erythematosus during the course of treatment].
Gritsman NN; Akhnazarova VD; Ivanova MM; Solov'ev SK
Revmatologiia (Mosk); 1983; (2):41-5. PubMed ID: 6353514
[No Abstract] [Full Text] [Related]
12. Clonality of the spontaneous immune response to DNA in murine lupus.
Cavallo T; Granholm NA; Graves K; Izui S
J Clin Lab Immunol; 1986 Jun; 20(2):81-7. PubMed ID: 3488408
[TBL] [Abstract][Full Text] [Related]
13. [Long-term course of 32 cases of diffuse proliferative lupus glomerulonephritis, treated with corticoids alone or combined with cyclophosphamide].
Jungers P; Dougados M; Tron F; Leibowitch J; Lesavre P; Droz D; Bach JF
J Urol Nephrol (Paris); 1979 Dec; 85(12):855-8. PubMed ID: 554871
[No Abstract] [Full Text] [Related]
14. Systemic lupus erythematosus--immunoregulatory therapies.
Miller ML; Steinberg AD
Clin Rheum Dis; 1983 Dec; 9(3):617-28. PubMed ID: 6360516
[No Abstract] [Full Text] [Related]
15. High dose intravenous corticosteroid therapy of systemic lupus erythematosus and primary cresenteric rapidly progressive glomerulonephritis. Proceedings of a symposium. Helsinki, September 16th, 1983.
Scand J Rheumatol Suppl; 1984; 54():1-33. PubMed ID: 6592748
[No Abstract] [Full Text] [Related]
16. [Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].
Heras M; Saiz A; Fernández-Reyes MJ; Sánchez R; Zurita P; Urrego C
Nefrologia; 2011; 31(2):231-3. PubMed ID: 21461001
[No Abstract] [Full Text] [Related]
17. Lupus nephritis: clinical course in relation to treatment.
Nanra RS; Kincaid-Smith P
Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1193-210. PubMed ID: 4803309
[No Abstract] [Full Text] [Related]
18. [The use of ultrahigh doses of corticosteroids in treating the most severe variants of lupus nephritis].
Ianushkevich TN; Klepikov PV
Ter Arkh; 1990; 62(6):50-3. PubMed ID: 2218927
[TBL] [Abstract][Full Text] [Related]
19. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
[No Abstract] [Full Text] [Related]
20. [Effect of cytotoxic immunosuppressive agents on the level of urinary seromucoids and cathepsins in lupus nephritis].
Stepanova NS; Solov'ev SK; Kaĭnova AS; Ivanova MM
Ter Arkh; 1980; 52(6):116-9. PubMed ID: 7404377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
